Tag Archives: roche

Feed Subscription

Roche takes another shot at sequencing

Roche takes another shot at sequencing

Roche Acquires Genia Technologies to Strengthen Next Generation Sequencing Pipeline Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of Genia Technologies, Inc. (Genia), a privately held company, based in Mountain View, California, USA. Genia is developing a single-molecule, ...

Read More »

Roche to Reorganize Sequencing Business

Measures aim to ensure sustained success in a fast-changing market environment Roche today announced changes to the management and set-up of its life-science business. The Applied Science Business Area will be dissolved and its portfolio of products integrated within Roche’s ...

Read More »

Roche vs Illumina – Round 3

Roche is increasing its offer to purchase Illumina from $44.50 to $51 per share. This represents a deal valued at almost $6.6 billion, cash.  Amazing! Though no deal has yet been struck, because this is a cash deal that has been ...

Read More »

Life Technologies weighs in on Roche – Illumina Deal

Last week an article appeared in BioArray News as part of the coverage of the ongoing Roche/Illumina story – Illumina Array Customers ‘Apprehensive’ of Possible Roche Takeover, Fear Platform ‘Stagnation’ Yesterday, I received an email from Life Technologies (I guess ...

Read More »

Roche vs Illumina – Round 2

Last week, Roche released a plan to take over Illumina’s Board. Roche announced that it has provided notice to Illumina, Inc. that it will nominate a slate of highly qualified, independent candidates for election to Illumina’s Board of Directors and ...

Read More »

Roche vs Illumina – Round 1

On Tuesday, Roche announced a $5.7 Billion hostile takeover bid for Illumina. Roche said it is making its proposal after “multiple efforts to engage with Illumina in order to reach a negotiated transaction,” were rebuffed. Under the terms of its ...

Read More »

Q3 Results – Top Sequencing Technology Players

From GenomeWeb Illumina’s Q3 Revenues Jump 50 Percent on Strength of HiSeq Illumina reported after the close of the market Tuesday that its third-quarter revenues jumped 50 percent, easily beating analysts’ consensus estimate. Life Technologies’ Q3 Revenues Rise 8 Percent ...

Read More »
Scroll To Top